z-logo
Premium
Alpha 2A ‐Adrenergic Versus Imidazoline Receptor Controversy in Rilmenidine's Action: Alpha 2A ‐Antagonism in Humans Versus Alpha 2A ‐Agonism in Rabbits
Author(s) -
MOLDERINGS GERHARD J.,
BÖNISCH HEINZ,
BRUSS MICHAEL,
GÖTHERT MANFRED
Publication year - 2003
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1304.036
Subject(s) - imidazoline receptor , oxymetazoline , alpha (finance) , rilmenidine , alpha 2 adrenergic receptor , antagonism , adrenergic receptor , pharmacodynamics , pharmacology , chemistry , endocrinology , receptor , medicine , adrenergic , agonist , biology , biochemistry , pharmacokinetics , patient satisfaction , construct validity , nursing
A bstract : At the a 2A ‐autoreceptors on the sympathetic nerve terminals of the human atrial appendages and rabbit pulmonary artery, rilmenidine and oxymetazoline exhibit different properties (antagonism and agonism, respectively). These opposite pharmacodynamic properties of a 2 ‐adrenoceptor ligands seem to be due to substantial differences in the nucleotide and amino acid sequences between human and rabbit a 2A ‐adrenoceptors. Hence, the rabbit a 2A ‐adrenoceptor is not reliably predictive for the action of ligands at the human a 2A ‐adrenoceptor.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom